Pharmaceutical giant GSK has agreed to buy US cancer drug firm Nuvalent in a 10.6 billion US dollar (£8 billion) deal as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results